US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 3.1474
- -0.0426-1.34%
Trading Aug 27 09:52 ET
5.04MMarket Cap-262P/E (TTM)
3.2503High2.9600Low15.29KVolume3.2500Open3.1900Pre Close48.62KTurnover1.17%Turnover RatioLossP/E (Static)1.60MShares32.850052wk High1.34P/B4.12MFloat Cap2.110052wk Low--Dividend TTM1.31MShs Float36000.0000Historical High--Div YieldTTM9.10%Amplitude2.1100Historical Low3.1800Avg Price1Lot Size
Alaunos Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00%4K | 1K | -99.83%5K | -90.91%1K | 0 | 4K | 0 | 634.17%2.92M | 11K | 631.41%2.91M |
| Operating revenue | 0.00%4K | --1K | -99.83%5K | -90.91%1K | --0 | --4K | --0 | 634.17%2.92M | --11K | 631.41%2.91M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -85.79%1.17M | -81.98%1.74M | -25.32%28.5M | -60.61%3.36M | -35.27%7.23M | -12.12%8.23M | 6.46%9.67M | -50.57%38.16M | -17.25%8.53M | -50.76%11.18M |
| Selling and administrative expenses | -67.49%990K | -48.96%1.62M | -7.02%12.22M | -16.99%2.43M | 9.02%3.58M | -11.20%3.05M | -9.61%3.17M | -52.32%13.14M | 39.62%2.93M | -59.84%3.28M |
| -General and administrative expense | -67.49%990K | ---- | -7.02%12.22M | -16.99%2.43M | 9.02%3.58M | --3.05M | ---- | -52.32%13.14M | --2.93M | --3.28M |
| Research and development costs | -96.53%180K | -98.06%126K | -34.93%16.28M | -83.36%933K | -53.68%3.66M | -12.65%5.19M | 16.56%6.5M | -49.60%25.02M | -31.76%5.61M | -45.64%7.89M |
| Operating profit | 85.83%-1.17M | 81.99%-1.74M | 19.14%-28.49M | 60.57%-3.36M | 12.46%-7.23M | 12.16%-8.23M | -6.46%-9.67M | 54.12%-35.24M | 17.36%-8.52M | 62.94%-8.26M |
| Net non-operating interest income expense | 0 | 0 | 39.09%-1.92M | 0 | 0 | -44.32%-1.07M | -24.89%-853K | -165.26%-3.15M | -19.19%-888K | -89.41%-841K |
| Non-operating interest expense | --0 | --0 | -39.09%1.92M | --0 | --0 | 44.32%1.07M | 24.89%853K | 165.26%3.15M | 19.19%888K | 89.41%841K |
| Other net income (expense) | -92.91%37K | -87.42%60K | -813.90%-4.73M | -1,893.20%-4.48M | -588.98%-1.24M | 200.00%522K | 2,485.00%477K | 187.92%662K | 133.88%250K | 3,528.57%254K |
| Special income (charges) | --0 | ---- | -4,441.35%-5.77M | ---4.59M | ---1.43M | 84.21%245K | ---- | 117.97%133K | --0 | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | --1.27M | --850K | --419K | ---- | ---- | --0 | --0 | --0 |
| -Less:Impairment of capital assets | ---- | ---- | --4.8M | --3.79M | --1.01M | ---- | ---- | --0 | --0 | --0 |
| -Less:Other special charges | ---- | ---- | -124.06%-298K | ---53K | ---- | -84.21%-245K | ---- | ---133K | --0 | ---- |
| Other non- operating income (expenses) | -86.64%37K | -87.42%60K | 98.11%1.05M | -57.60%106K | -25.98%188K | 575.61%277K | 2,485.00%477K | 4,169.23%529K | 12,400.00%250K | 3,528.57%254K |
| Income before tax | 87.13%-1.13M | 83.26%-1.68M | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M |
| Income tax | ||||||||||
| Net income | 87.13%-1.13M | 83.26%-1.68M | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M |
| Net income continuous Operations | 87.13%-1.13M | 83.26%-1.68M | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 87.13%-1.13M | 83.26%-1.68M | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 87.13%-1.13M | 83.26%-1.68M | 6.86%-35.14M | 14.37%-7.84M | 4.24%-8.48M | 11.67%-8.77M | -2.66%-10.05M | 52.09%-37.73M | 22.34%-9.16M | 61.07%-8.85M |
| Basic earnings per share | 87.07%-0.71 | 82.54%-1.1 | 15.71%-330 | 18.37%-4.898 | 0.00%-6 | 26.80%-5.49 | 16.00%-6.3 | -605.41%-391.5 | 20.00%-6 | 63.64%-6 |
| Diluted earnings per share | 87.07%-0.71 | 82.54%-1.1 | 15.71%-330 | 18.37%-4.898 | 0.00%-6 | 26.80%-5.49 | 16.00%-6.3 | -605.41%-391.5 | 20.00%-6 | 63.64%-6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
